An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to coronavirus disease (COVID-19), a global health pandemic causing millions of deaths worldwide. However, the immunopathogenesis of COVID-19, particularly the interaction between SARS-CoV-2 and host innate immunit...
Saved in:
Main Authors: | Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/481e8539bb824e7da5e1c5b29b4caeea |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
by: Kei Amemiya, et al.
Published: (2021) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
by: Amani E. Khalifa, PhD, et al.
Published: (2021) -
Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective
by: Wang Z, et al.
Published: (2020) -
Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
by: Hi Eun Jung, et al.
Published: (2021) -
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
by: Kelsey A. Gregg, et al.
Published: (2017)